CD44 and lung adenocarcinoma: As the relationship between CSCs and mutant p53 in lung adenocarcinoma is not well established, the question of whether the same role of CD44+ and CD133+ cells in escaping p53 mutant NSCLC cell death after radiotherapy remains to be addressed.